News Conference News CRT 2025 AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years L.A. McKeown March 10, 2025
News Conference News CRT 2024 Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries L.A. McKeown March 14, 2024
News Conference News CRT 2024 Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis L.A. McKeown March 09, 2024
News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022
News Conference News CRT 2021 Polymer-Free Stent Noninferior to ZES at 3 Years: ReCre8 Yael L. Maxwell March 18, 2021
News Daily News CRT 2021 COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold Michael O'Riordan March 17, 2021
News Conference News CRT 2021 BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients Caitlin E. Cox March 16, 2021
News Conference News CRT 2020 Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback Michael O'Riordan February 28, 2020
News Conference News CRT 2020 BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis L.A. McKeown February 25, 2020
News Conference News CRT 2018 Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT Michael O'Riordan March 08, 2018
News Conference News CRT 2017 Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate Michael O'Riordan February 21, 2017